A decline in first‑phase insulin response (FPIR) during the presymptomatic period of type 1 diabetes (T1D) is a well established observation. Despite this, the molecular mechanisms that drive β‑cell dysfunction before clinical onset are not fully defined. The authors applied an in‑situ, whole‑islet phenotypical and transcriptomic strategy using pancreas tissue from human donors across the natural history of T1D to identify transcriptional alterations in pathways linked to stimulus‑coupled insulin secretion and β‑cell health.
The study interrogated pancreas tissue sections and performed paired phenotypic and transcriptomic analyses on intact islets in situ. Donor pancreas tissue represented stages across T1D natural history, including autoantibody positive (AAb+) donors (single or multiple AAb+) and donors with established T1D, including those with disease duration <7 years. The provided abstract does not report sample sizes, detailed experimental protocols, sequencing platforms, bioinformatic pipelines, or statistical thresholds; these details were not available in the source text.
Islets from autoantibody positive donors demonstrated transcriptional activation of pathways associated with post‑transcriptional gene regulation. Concomitantly, these islets showed transcriptional signatures indicative of reduced protein translation and decreased processing activities in the endoplasmic reticulum (ER). The abstract reports that ER stress signatures were reduced at the transcriptional level in these AAb+ islets. These findings indicate early disruption of the cellular machinery responsible for protein synthesis and maturation prior to overt clinical disease.
Disrupted mitochondrial metabolism and bioenergetics emerged as prominent transcriptional features in islets from multiple AAb+ donors and in islets from T1D donors with disease duration under seven years. The reported impairments implicate mitochondrial pathways that support β‑cell metabolic coupling and ATP generation, processes that are essential for glucose‑stimulated insulin secretion. The abstract highlights these mitochondrial transcriptional changes as a key signal of early β‑cell dysfunction.
Across AAb+ islets, the transcriptome suggested downregulation of protein synthesis and ER processing capacity, paired with a reduction in canonical ER stress transcriptional markers. These concurrent signals—reduced translation and reduced ER stress transcripts—suggest a complex remodeling of protein‑homeostasis pathways in preclinical disease stages. The abstract does not provide gene‑level examples, quantitative effect sizes, or corroborating proteomic or functional measurements.
T1D islets exhibited transcriptional downregulation of genes involved in the insulin secretory pathway. This pattern, together with impaired mitochondrial function and altered protein‑homeostasis programs, points to multi‑level transcriptional dysregulation of the glucose stimulus–secretion coupling cascade in islets during disease progression. The abstract indicates these secretory pathway changes occur in both infiltrated and non‑infiltrated islets but does not list specific genes or functional readouts.
During T‑cell infiltration of islets, the mitochondrial and protein‑homeostasis pathways described above remained transcriptionally dysregulated, while immune and inflammatory transcripts increased. The authors note that impaired pathways in glucose‑stimulus coupled secretion were similarly affected in both T‑cell infiltrated and non‑infiltrated islets, implying β‑cell intrinsic transcriptional defects that are not solely secondary to local immune infiltration.
The content summarized here is derived from the abstract of a preprint. The abstract truncates near its conclusion and the full manuscript text was not provided in the source material. Consequently, important experimental details are not reported in the supplied text, including: donor numbers and clinical characteristics, precise definitions of single versus multiple AAb+ categories, lists of differentially expressed genes, quantitative measures of transcriptional change, statistical significance thresholds, validation experiments, and functional or proteomic corroboration. Because these details were not reported in the source, they cannot be inferred or added.
The study, as reported, identifies transcriptional impairment of mitochondrial and protein‑homeostasis pathways in human islets during the presymptomatic and early symptomatic stages of T1D, and indicates that these impairments coexist with increased immune/inflammatory transcripts during infiltration. Additional data and the complete manuscript would be required to evaluate the specific genes involved, effect sizes, and potential mechanistic or therapeutic implications.